Is Recursion Pharmaceuticals, Inc. (RXRX) a Buy, Sell, or Hold?
Recursion Pharmaceuticals, Inc.
NASDAQ:RXRX
$3.35 USD
$0.01 (0.3%)
- Volume
- 8.28M
- Average Volume
- 19.03M
- Market Capitalization
- $1.5B
- P/E Ratio
- -2.79
- Dividend Yield
- 0.00%
- Price Target
- $5.50
- Year High
- $7.18
- Year Low
- $2.77
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $5.47
| Date | EPS Estimated | Time | Revenue | Revenue Estimated |
|---|---|---|---|---|
| 2026-08-04 | -0.25 | After Market Close | $- | $10.97M |
| 2026-05-06 | -0.30 | After Market Close | $6.3M | $15.78M |
| 2026-02-25 | -0.28 | After Market Close | $35.35M | $24.54M |
| 2025-11-05 | -0.38 | After Market Close | $5.18M | $24.56M |
| 2025-08-05 | -0.35 | After Market Close | $19.1M | $19.92M |
| 2025-05-05 | -0.44 | After Market Close | $14.74M | $13.96M |
| 2025-02-28 | -0.44 | After Market Close | $4.51M | $19.04M |
| 2024-11-06 | -0.33 | After Market Close | $26.08M | $18.17M |
| 2024-08-08 | -0.35 | After Market Close | $14.42M | $13.26M |
| 2024-05-09 | -0.43 | After Market Close | $13.79M | $12.65M |
| 2024-02-27 | -0.46 | After Market Close | $10.89M | $20.35M |
| 2023-11-09 | -0.38 | After Market Close | $10.1M | $20.53M |
| 2023-08-08 | -0.38 | After Market Close | $11.02M | $11.91M |
| 2023-05-08 | -0.34 | After Market Close | $12.13M | $14.44M |
| 2023-02-27 | -0.15 | After Market Close | $13.68M | $23.8M |
| 2022-11-08 | -0.36 | After Market Close | $13.05M | $6.84M |
| 2022-08-09 | -0.35 | After Market Close | $7.65M | $5.33M |
| 2022-05-10 | 0.51 | After Market Close | $5.3M | $83.95M |
| 2022-03-23 | -0.30 | After Market Close | $2.5M | $6.03M |
| 2021-11-10 | -0.28 | After Market Close | $2.5M | $2.53M |
| 2021-08-13 | -0.23 | After Market Close | $2.5M | $2.55M |
| 2021-05-12 | After Market Close | $2.5M | $- | |
| 2021-04-16 | After Market Close | $2.55M | $- | |
| 2020-09-30 | After Market Close | $862K | $- | |
| 2020-06-30 | After Market Close | $186K | $- | |
| 2020-03-31 | After Market Close | $60000 | $- |